James Molloy
Stock Analyst at Alliance Global Partners
(0.51)
# 3,812
Out of 4,814 analysts
33
Total ratings
23.53%
Success rate
-42.01%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.28 | +1,157.18% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $1.85 | +359.46% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $19.70 | +77.66% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $0.84 | +1,679.78% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $7.35 | +172.11% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $14 | $6.02 | +132.56% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $15.71 | +6,901.91% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.56 | +212.50% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.09 | +223.62% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $1.75 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.95 | +1,376.79% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.03 | +2,812.62% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.02 | +635.29% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $4.84 | +313.22% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.30 | +515.38% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $2.49 | +181.69% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.27 | +6,199.21% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.71 | +2,142.15% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.36 | +3,756.75% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.85 | +1,664.71% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $5.49 | +152,905.46% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.56 | +9,546.30% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.17 | +80,028.21% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.01 | +1,146.88% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.28
Upside: +1,157.18%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $1.85
Upside: +359.46%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $19.70
Upside: +77.66%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.84
Upside: +1,679.78%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $7.35
Upside: +172.11%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $14
Current: $6.02
Upside: +132.56%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $15.71
Upside: +6,901.91%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.56
Upside: +212.50%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.09
Upside: +223.62%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.75
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.95
Upside: +1,376.79%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.03
Upside: +2,812.62%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.02
Upside: +635.29%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $4.84
Upside: +313.22%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.30
Upside: +515.38%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $2.49
Upside: +181.69%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.27
Upside: +6,199.21%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.71
Upside: +2,142.15%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.36
Upside: +3,756.75%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.85
Upside: +1,664.71%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $5.49
Upside: +152,905.46%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $1.56
Upside: +9,546.30%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.17
Upside: +80,028.21%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.01
Upside: +1,146.88%